Oligonucleotide Synthesis Market worth $1,712.1 Million by 2019

1. MarketsandMarkets Presents Oligonucleotide Synthesis Market worth $1,712.1 Million by 2019 http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

2. The Report “Oligonucleotide Synthesis Market by Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical & Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - Global Forecast to 2019” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the oligonucleotide synthesis market along with the estimates and forecasts of the revenue and competitive analysis. Browse 84 market data tables and 40 figures spread through 185 pages and in-depth TOC on “Oligonucleotide Synthesis Market by Product & Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical & Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAI) - Global Forecast to 2019”  http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

3. Early buyers will receive 10% customization on this report. http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

4. The global oligonucleotide synthesis market is expected to reach $1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a CAGR of 9.8% from 2014 to 2019. • Based on products and services, the market is broadly segmented into equipment, reagents, and synthesized oligonucleotides. Among these segments, the synthesized oligonucleotides market segment is expected to register the highest growth rate during the forecast period, owing to the increasing number of applications of synthesized oligonucleotides in research, diagnostics and therapeutics; and a growing demand for custom oligos. http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

5. The market by applications is classified into diagnostics, research, and therapeutics. Research applications are further segmented into PCR, qPCR, sequencing, gene synthesis, and others. The therapeutics market is further segmented into DNA/antisense oligos, RNAi, aptamers, and others. In terms of applications, the research segment commanded the largest share in 2014, while the diagnostics segment is forecasted to be the fastest-growing segment in the oligonucleotide synthesis market. By end users, the market is segmented into academic research institutes, pharmaceutical and biotech firms, and diagnostic labs. Academic research institutes contributed the major market share in 2014; however, diagnostic laboratories are expected to be the fastest-growing end user segment during the forecast period. http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

6. Based on geography, the global oligonucleotide synthesis market is segmented into North America, Latin America, Europe, Middle East and Africa, and Asia-Pacific (APAC). North America is expected to account for the largest share of the market in 2014. However, Asia-Pacific is poised to grow at the highest CAGR during the forecast period, owing to increase in research and development activities, rising R&D funding and growing availability of synthesized oligos in the region. http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

7. Prominent players in the oligonucleotide synthesis market are Agilent Technologies, Inc. (U.S.), BioAutomation Corporation (U.S.), BioSearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GE Healthcare (U.K.), Glen Research (U.S.), Gene Link, Inc. (U.S.), GenScript USA, Inc. (U.S.), GeneDesign, Inc. (Japan), Integrated DNA Technologies, Inc. (IDT) (U.S.), Link Technologies, Ltd. (U.K.), Nitto Denko Avecia, Inc. (U.S.), Sigma-Aldrich Co. LLC. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and TriLinkBioTechnologies, Inc. (U.S.). http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

8. Contact Us Contact: Mr. Rohan 1 South Dearborn Street, 21st Floor , Chicago, Illinois, 60603, United States Tel: + 1-888-600-6441 Email: sales@marketsandmarkets.comhttp://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

9. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. They cover thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html